Charity Milam
Primary Care · Southaven, MSNPI 1528429214
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations.
Across 131 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$345
- Lilly USA, LLC$306
- Abbott$259
- Boehringer Ingelheim$208
- Nevro Corp.$205
- Bayer$182
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,669100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $345 |
| Lilly USA, LLC | 21 | $306 |
| Abbott | 5 | $259 |
| Boehringer Ingelheim | 14 | $208 |
| Nevro Corp. | 2 | $205 |
| Bayer | 5 | $182 |
| AstraZeneca | 10 | $176 |
| GSK | 9 | $151 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $95 |
| AbbVie | 5 | $82 |
| Johnson & Johnson | 5 | $75 |
| Shield Therapeutics Inc | 4 | $70 |
| Astellas Pharma US Inc | 3 | $69 |
| Amgen | 3 | $56 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Lundbeck LLC | 2 | $40 |
| Amarin Pharma, Inc. | 2 | $37 |
| Merck | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Mylan Specialty L.p. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Pfizer | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Corcept Therapeutics | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
| Evoke Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$176
- Kerendia$121
- Omnia$109
How this compares
$2,669 in reported general payments places this provider in the 85th percentile of 80 primary care providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $53,063 |
| EliquisApixaban | 24 | $33,487 |
| MounjaroTirzepatide | 32 | $32,748 |
| JardianceEmpagliflozin | 21 | $32,690 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $24,764 |
| LinzessLinaclotide | 18 | $21,463 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 635 | $13,494 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 484 | $8,515 |
| BelsomraSuvorexant | 12 | $5,223 |
| Gabapentin | 132 | $2,217 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 62 | $1,699 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 32 | $1,323 |
| Olmesartan Medoxomil | 57 | $1,138 |
| Lidocaine | 13 | $1,019 |
| Tizanidine Hcl | 98 | $932 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $345 | $53,06345 claims |
| PfizerEliquis | $19 | $33,48724 claims |
| Lilly USA, LLCMounjaro | $306 | $32,74832 claims |
| Boehringer IngelheimJardiance | $208 | $32,69021 claims |
| GSKTrelegy Ellipta | $151 | $24,76422 claims |
| AbbVieLinzess | $82 | $21,46318 claims |
| MerckBelsomra | $37 | $5,22312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 80 primary care providers in Mississippi.
Other primary care in Southaven
- Katrina BlackardSouthaven$14K
- Irene WilsonSouthaven$4K
- Lauren BakerSouthaven$2K
- Alisha McArthur WilkesRidgeland$17K
- Sarah HarringtonTupelo$11K
- Julie HarperNewhebron$10K
- Hannah IvisonJackson$10K
- Mary EatonTupelo$4K
- Tanya SandersonTupelo$3K
- Amanda EllisKosciusko$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.